Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) Equity Ratio: 2015-2025

Historic Equity Ratio for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to 0.36.

  • AC Immune's Equity Ratio rose 18527.46% to 0.36 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36, marking a year-over-year increase of 18527.46%. This contributed to the annual value of 0.00 for FY2025, which is N/A change from last year.
  • Per AC Immune's latest filing, its Equity Ratio stood at 0.36 for Q3 2025, which was down 7.39% from 0.39 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Equity Ratio ranged from a high of 0.94 in Q2 2022 and a low of 0.00 during Q3 2024.
  • In the last 3 years, AC Immune's Equity Ratio had a median value of 0.45 in 2025 and averaged 0.44.
  • As far as peak fluctuations go, AC Immune's Equity Ratio soared by 75,572.70% in 2021, and later crashed by 99.78% in 2024.
  • AC Immune's Equity Ratio (Quarterly) stood at 0.89 in 2021, then increased by 2.43% to 0.91 in 2022, then declined by 3.32% to 0.88 in 2023, then tumbled by 44.67% to 0.49 in 2024, then spiked by 18,527.46% to 0.36 in 2025.
  • Its Equity Ratio was 0.36 in Q3 2025, compared to 0.39 in Q2 2025 and 0.45 in Q1 2025.